The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581 · cited 2×
“For this reason, NAFLD has been regarded as a hepatic manifestation of metabolic syndrome [6].”
BackgroundNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
National Health and Nutrition Examination Survey
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6177 · Cited by 2,087
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
Choi, H. K., & Ford, E. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.040 · Cited by 601
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3541 · Cited by 574
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Targher, G., & Arcaro, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551
Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?
Nieto, F. J., Iribarren, C., Gross, M. D., Comstock, G. W., & Cutler, R. G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00214-2 · Cited by 480
Jimba, S., Nakagami, T., Takahashi, M., Wakamatsu, T., Hirota, Y., Iwamoto, Y., & Wasada, T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01582.x · Cited by 455
Effect of insulin on uric acid excretion in humans
Quinones Galvan, A., Natali, A., Baldi, S., Frascerra, S., Sanna, G., Ciociaro, D., & Ferrannini, E. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.1.e1 · Cited by 451
Relationship Between Serum Uric Acid Concentration and Insulin Resistance and Metabolic Syndrome
Yoo, T. W., Sung, K. C., Shin, H. S., Kim, B. J., Kim, B. S., Kang, J. H., Lee, M. H., Park, J. R., Kim, H., Rhee, E. J., et al. (2005) · Circulation Journal · doi:10.1253/circj.69.928 · Cited by 412
Sookoian, S., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 406
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
Fan, J.-G., Zhu, J., Li, X.-J., Chen, L., Li, L., Dai, F., Li, F., & Chen, S.-Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.042 · Cited by 404
Hayden, M. R., & Tyagi, S. C. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-10 · Cited by 397
Amarapurkar, D. N., Hashimoto, E., Lesmana, L. A., Sollano, J. D., Chen, P., Goh, K., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05042.x · Cited by 395
Molecular Physiology of Urate Transport
Hediger, M. A., Johnson, R. J., Miyazaki, H., & Endou, H. (2005) · Physiology · doi:10.1152/physiol.00039.2004 · Cited by 353
Effect of insulin on renal sodium and uric acid handling in essential hypertension
Muscelli, E. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00098-2 · Cited by 314
Systemic Uric Acid Administration Increases Serum Antioxidant Capacity in Healthy Volunteers
W. Waring, S., J. Webb, D., & R. J. Maxwell, S. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200109000-00005 · Cited by 294
What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?
Fan, J., Saibara, T., Chitturi, S., Kim, B. I., Sung, J. J. Y., Chutaputti, A., & NAFLD, T. A. W. P. F. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04952.x · Cited by 267
Elevated serum uric acid ? a facet of hyperinsulinaemia
Modan, M., Halkin, H., Karasik, A., & Lusky, A. (1987) · Diabetologia · doi:10.1007/bf00296994 · Cited by 263
Uric acid metabolism and tubular sodium handling. Results from a population-based study
Cappuccio, F. P. (1993) · JAMA · doi:10.1001/jama.270.3.354 · Cited by 233
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Paschou, S. A., Polyzos, S. A., Anagnostis, P., Goulis, D. G., Kanaka-Gantenbein, C., Lambrinoudaki, I., Georgopoulos, N. A., & Vryonidou, A. (2020) · Endocrine · doi:10.1007/s12020-019-02085-7 · Cited by 231
Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice
García-Ruiz, I., Rodríguez-Juan, C., Díaz-Sanjuan, T., del Hoyo, P., Colina, F., Muñoz-Yagüe, T., & Solís-Herruzo, J. A. (2006) · Hepatology · doi:10.1002/hep.21313 · Cited by 189
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Cerda, C., Pérez-Ayuso, R. M., Riquelme, A., Soza, A., Villaseca, P., Sir-Petermann, T., Espinoza, M., Pizarro, M., Solis, N., Miquel, J. F., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.012 · Cited by 187
Uric Acid Metabolism and Tubular Sodium Handling: Results From a Population-Based Study
Cappuccio, F. P. (1993) · JAMA · doi:10.1001/jama.1993.03510030078038 · Cited by 158
Lonardo, A., Loria, P., Leonardi, F., Borsatti, A., Neri, P., Pulvirenti, M., Verrone, A. M., Bagni, A., Bertolotti, M., Ganazzi, D., et al. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80194-3 · Cited by 146
Patterson, R. A., Horsley, E. T. M., & Leake, D. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200407-jlr200 · Cited by 143
Review article: role of oxidative stress in the progression of non‐alcoholic steatosis
Albano, E., Mottaran, E., Occhino, G., Reale, E., & Vidali, M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02601.x · Cited by 134
Serum leptin is associated with serum uric acid concentrations in humans
Fruehwald‐Schultes, B., Peters, A., Kern, W., Beyer, J., & Pfützner, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90163-4 · Cited by 97
Endothelial effects of leptin: Implications in health and diseases
Rahmouni, K., & Haynes, W. G. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0020-5 · Cited by 60
Lee, S. Y., Kim, Y. J., Jeon, T. Y., Kim, H. H., Oh, S. W., Park, Y., & Kim, S. S. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500319591 · Cited by 57
Elevated Serum Leptin Concentrations in Women with Hyperuricemia.
Matsubara, M., Chiba, H., Maruoka, S., & Katayose, S. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.28 · Cited by 51
Baba, T., AMASAKI, Y., Soda, M., Hida, A., Imaizumi, M., Ichimaru, S., Nakashima, E., Seto, S., Yano, K., & Akahoshi, M. (2007) · Hypertension Research · doi:10.1291/hypres.30.823 · Cited by 36
Cited by
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.002 · Cited by 711
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
Lanaspa, M. A., Sanchez-Lozada, L. G., Choi, Y.-J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C. A., Ishimoto, T., Li, N., Marek, G., Duranay, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399899 · Cited by 710
Metadata
- Authors
- Li, Y., Xu, C., Yu, C., Xu, L., & Miao, M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 50
- Issue
- 5
- Pages
- 1029-1034
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1973450715
- Cited by
- 264
- References
- 39
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.